About Us
The Muzzi Mirza Pancreatic Cancer Prevention and Genetics Program is comprised of both a clinical division that focuses on treatment of individuals who are at an elevated risk of developing pancreatic cancer as well as a robust research program that focuses on identifying new and innovative early detection methods as well as new risk factors. Through routine screening and genetic testing we aim to detect the potentially devastating disease early, and thereby improving the survival rate of people diagnosed with pancreatic cancer.
The team:
Fay Kastrinos, MD
Elana Levinson, MS, MPH
Lauren Khanna, MD
Ashley Dikos, MPH
